磁共振成像对前列腺癌分期及欧洲泌尿外科学会风险分类的影响
单中心分析180例机器人辅助根治性前列腺切除术前接受直肠指检与MRI临床分期前列腺癌患者,按EAU指南分4个风险类别。以MRI替代直肠指检信息导致临床T分期和EAU风险分组显著上调(分别为33%和31%),MRI检测非器官局限前列腺癌敏感性高于直肠指检(59% vs 41%,P<.01)但特异性较低(69% vs 95%,P<.01),治疗决策改变49/180例(27%)。
要点
- 以MRI替代直肠指检信息导致33%患者临床T分期上调、31%患者EAU风险分组上调。
- MRI检测非器官局限前列腺癌敏感性59% vs 直肠指检41%(P<.01),特异性69% vs 95%(P<.01)。
- 将MRI分期纳入治疗决策过程会改变49/180例(27%)患者的手术治疗策略。
核心结论
- 与使用基于直肠指检信息的现行EAU指南相比,纳入MRI信息会显著影响前列腺癌患者的治疗选择。
- 更具体而言,每4例患者中约有1例会被建议进行治疗强化。
研究设计与样本
- 单中心分析180例前列腺癌患者,均在机器人辅助根治性前列腺切除术前行直肠指检和MRI临床分期。
- 根据直肠指检或MRI评估的临床T分期,按EAU指南将患者分为4个明确的风险类别。
- 分类变量以频率和比例进行描述性统计,两种情景(直肠指检分期 vs MRI分期)的差异采用配对样本符号检验分析。
主要发现
- 使用MRI信息而非直肠指检信息导致临床T分期显著上调(33%)和EAU风险分组显著上调(31%)。
- 与病理T分期比较,MRI检测非器官局限前列腺癌的敏感性高于直肠指检(59% vs 41%;P<.01)。
- MRI的特异性低于直肠指检(69% vs 95%;P<.01)。
- 在治疗决策过程中纳入基于MRI而非基于直肠指检的分期,会改变49/180例患者(27%)的手术治疗策略。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of magnetic resonance imaging (MRI) information on clinical staging, risk stratification, and treatment recommendations for prostate cancer (PCa) according to the European Association of Urology (EAU) guidelines. METHODS: We performed a single-center analysis of 180 men with PCa, undergoing clinical staging by digital rectal examination (DRE) as well as MRI before their robot-assisted radical prostatectomy. Patients were stratified according to the EAU guidelines into 4 well-defined risk categories, based on their clinical T-stage assessed by either DRE or MRI. Descriptive statistics of categorical variables are shown as frequencies and proportions. Differences between both scenarios (DRE- vs MRI-staged) were analyzed using a paired-samples sign test. RESULTS: Use of MRI information instead of DRE information leads to significant upstaging of clinical T-stage (33%) and EAU risk grouping (31%). When comparing these results with the pathologic T-stage, MRI showed a higher sensitivity than DRE to detect nonorgan-confined PCa (59% vs 41%; P <.01). In contrast, the specificity of MRI was lower than DRE (69% vs 95%; P <.01). Incorporation of MRI-based instead of DRE-based staging in the treatment decision process would alter the surgical treatment strategy in 49/180 patients (27%). CONCLUSION: The incorporation of MRI information substantially affects the treatment choice in PCa patients as compared to using the current available EAU guidelines based on DRE information. More specifically, treatment intensification would be recommended in 1 out of 4 patients.
引用
- Draulans C, Everaerts W, Isebaert S, et al. Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification. Urology. 2019. PMID: 31051166. doi:10.1016/j.urology.2019.04.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。